Featured Article
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Gut Bacteria Can Help Create Artificial Group O Blood
Enzymes derived from gut bacteria could help solve the problem of a lack of O blood type donors, by transforming other types of blood into O.
The Human Immunome Project Plans to Unlock the Immune System’s Secrets
The Human Immunome Project has revealed plans to decode and model the immune system by generating the largest immunological dataset to date.
High Throughput Optical Genome Mapping Unleashed
In this session, we will explore the potential of optical genome mapping (OGM) in addressing hematological malignancy and complex genetic disease insights. Our speakers’ discussions will showcase the leading-edge applications and impacts of OGM in revolutionizing the understanding and management of hematological and constitutional diseases across Europe.